FindTrial
Sign In

In vitro function study for T cell antigen receptor T cell (TCR-T) immunotherapy

In vitro function study for T cell antigen receptor T cell (TCR-T) immunotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044291
Enrollment
Unknown
Registered
2021-03-14
Start date
2021-03-22
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

Case series:Not applicable

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Refer to the standard of blood donation

Exclusion criteria

Exclusion criteria: 1) Volunteers with clinically serious diseases of respiratory system, circulatory system, blood system, immune system, etc. are not suitable for donation; 2) Volunteers who are known to have blood-borne diseases (AIDS, hepatitis C, hepatitis B, syphilis, etc.) are not suitable for donation; 3) Other researchers believe that volunteers are not suitable for single blood donation.

Design outcomes

Primary

MeasureTime frame
TCR-T cells function in vitro;—

Countries

China

Contacts

Public ContactGeng Tian

Shenzhen Second People's Hospital

tiangeng666@aliyun.com+86 18124198640

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026